Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alex Wodak

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|December 25, 2007
Responding to HIV in AfghanistanSaif-ur-Rehman, Mohammad Zafar Rasoul, Alex Wodak, et al.
The Medical Journal of Australia|June 4, 2004
Using AUDIT to classify patients into Australian Alcohol Guideline categoriesJulia E Fawcett, Anthony P Shakeshaft, Mark F Harris, et al.
Addiction (Abingdon, England)|May 9, 2025
Response to letter commenting on: Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies?Colin Paul Mendelsohn, Robert Beaglehole, Ron Borland, et al.
Addiction (Abingdon, England)|February 9, 2025
Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies?Colin Paul Mendelsohn, Robert Beaglehole, Ron Borland, et al.
Harm Reduction Journal|October 17, 2015
Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in AsiaPascal Tanguay, Adeeba Kamarulzaman, Apinun Aramrattana, et al.
Drug and Alcohol Dependence|January 6, 2010
Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of statusCarolyn A Day, Bethany White, Gregory J Dore, et al.
The International Journal on Drug Policy|February 2, 2010
Meth/amphetamine use and associated HIV: Implications for global policy and public healthLouisa Degenhardt, Bradley Mathers, Mauro Guarinieri, et al.
The Lancet. Infectious Diseases|May 4, 2004
Rationale for evaluating North America's first medically supervised safer-injecting facilityEvan Wood, Thomas Kerr, Julio S Montaner, et al.
Addiction (Abingdon, England)|January 20, 2009
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependenceJames Shearer, Shane Darke, Craig Rodgers, et al.
Journal of Paediatrics and Child Health|June 11, 2013
Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infantsPankaj Patel, Mohamed E Abdel-Latif, Briony Hazelton, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|December 25, 2007
Responding to HIV in AfghanistanSaif-ur-Rehman, Mohammad Zafar Rasoul, Alex Wodak, et al.
The Medical Journal of Australia|June 4, 2004
Using AUDIT to classify patients into Australian Alcohol Guideline categoriesJulia E Fawcett, Anthony P Shakeshaft, Mark F Harris, et al.
Addiction (Abingdon, England)|May 9, 2025
Response to letter commenting on: Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies?Colin Paul Mendelsohn, Robert Beaglehole, Ron Borland, et al.
Addiction (Abingdon, England)|February 9, 2025
Do the differing vaping and smoking trends in Australia and New Zealand reflect different regulatory policies?Colin Paul Mendelsohn, Robert Beaglehole, Ron Borland, et al.
Harm Reduction Journal|October 17, 2015
Facilitating a transition from compulsory detention of people who use drugs towards voluntary community-based drug dependence treatment and support services in AsiaPascal Tanguay, Adeeba Kamarulzaman, Apinun Aramrattana, et al.
Drug and Alcohol Dependence|January 6, 2010
Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of statusCarolyn A Day, Bethany White, Gregory J Dore, et al.
The International Journal on Drug Policy|February 2, 2010
Meth/amphetamine use and associated HIV: Implications for global policy and public healthLouisa Degenhardt, Bradley Mathers, Mauro Guarinieri, et al.
The Lancet. Infectious Diseases|May 4, 2004
Rationale for evaluating North America's first medically supervised safer-injecting facilityEvan Wood, Thomas Kerr, Julio S Montaner, et al.
Addiction (Abingdon, England)|January 20, 2009
A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependenceJames Shearer, Shane Darke, Craig Rodgers, et al.
Journal of Paediatrics and Child Health|June 11, 2013
Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infantsPankaj Patel, Mohamed E Abdel-Latif, Briony Hazelton, et al.
Pageof 8